Cambridge, MA, United States of America

Shan Shan Wu

This inventor holds 1 USPTO granted patent. Top assignee: Agency for Science, Technology and Research. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shan Shan Wu. Retrieved from https://idiyas.com/inventor/shan-shan-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Shan Shan Wu in Neurotrophin Research

Introduction

Shan Shan Wu is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of neurotrophin research, particularly through his innovative work on recombinant polypeptides. His research focuses on the development of novel therapeutic approaches for neurological disorders.

Latest Patents

Shan Shan Wu holds a patent for a recombinant polypeptide that is useful for neurotrophin receptor-mediated gene delivery and acts as a neurotrophin agonist. This invention provides a unique recombinant polypeptide that includes a nucleic acid binding element and a hairpin motif that selectively binds to a neurotrophin receptor. The recombinant polypeptide can facilitate the delivery of therapeutic DNA bound to it, enhancing treatment options for various neurological disorders and tumors.

Career Highlights

Wu is associated with the Agency for Science, Technology and Research, where he continues to advance his research in neurotrophin applications. His work has the potential to significantly impact the treatment of disorders responsive to neurotrophin treatment.

Collaborations

Some of his notable coworkers include Jieming Zeng and Nan Ma, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Shan Shan Wu's innovative work in the field of neurotrophins exemplifies the potential of recombinant polypeptides in medical applications. His contributions are paving the way for new therapeutic strategies in treating neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…